Skip to main content
Top
Published in: Virology Journal 1/2010

Open Access 01-12-2010 | Short report

Chitosan can stop or postpone the death of the suckling mice challenged with foot-and-mouth disease virus

Author: Dong Li

Published in: Virology Journal | Issue 1/2010

Login to get access

Abstract

In the study, a method called "hardening in liquid phase" for preparing chitosan granules with glutaraldehyde as crosslinker and Tween 80 as surfactant and paraffin liquid as dispersant was established. The chitosan granules were light yellow and insoluble in water or oil, but they swelled in acid solution and narrowed in neutral or alkaline solution. Furthermore, some of characteristics of the chitosan granules were revealed. (a) Stability: Their shapes were stable at pH 7.0 and pH 8.0 and -30°C~120°C. The shelf life is at least one year in vitro at room temperature. (b) Safety: Some experiments of their lethal effect to suckling mice and pathogenicity to mature mice proved the chitosan granules were harmless. (c) Antiviral activity: Some suckling mice injected with chitosan granules were still alive or delayed death compared with control group when they challenged with foot-and-mouth disease virus (FMDV). Such anti-FMDV capacity could maintain 1 week and was the strongest on the third day.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bacon A, Makin J, Sizer PJ, et al: Infect Immunity, Carbohydrate Biopolymers Enhance Antibody Responses to Mucosally Delivered Vaccine Antigens. 2000, 68 (10): 5764-5770. Bacon A, Makin J, Sizer PJ, et al: Infect Immunity, Carbohydrate Biopolymers Enhance Antibody Responses to Mucosally Delivered Vaccine Antigens. 2000, 68 (10): 5764-5770.
2.
go back to reference Sobrino F, Domingo E, (edited): Foot and Mouth Disease: Current perspectives. Horizon Bioscience. 2004, 189-191. Sobrino F, Domingo E, (edited): Foot and Mouth Disease: Current perspectives. Horizon Bioscience. 2004, 189-191.
3.
go back to reference Muzzareil RA: 1978, Chitin., pergamon press, New York, 139-140. Muzzareil RA: 1978, Chitin., pergamon press, New York, 139-140.
4.
go back to reference Muzzarelli RA, Mattioli-Belmonte M, Muzzarelli B, et al: Advances in Chitin, SciLyon: Andru. 1998, 2: 219-224. Muzzarelli RA, Mattioli-Belmonte M, Muzzarelli B, et al: Advances in Chitin, SciLyon: Andru. 1998, 2: 219-224.
5.
go back to reference Shibata Y, Foster LA, Metzger WJ, Myrvik QN: Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice. Infection and Immunity. 1997, 65 (5): 1734-1741.PubMedPubMedCentral Shibata Y, Foster LA, Metzger WJ, Myrvik QN: Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice. Infection and Immunity. 1997, 65 (5): 1734-1741.PubMedPubMedCentral
Metadata
Title
Chitosan can stop or postpone the death of the suckling mice challenged with foot-and-mouth disease virus
Author
Dong Li
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2010
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-7-125

Other articles of this Issue 1/2010

Virology Journal 1/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.